In a double-blind, randomized and placebo-controlled trial, adjuvant memantine improved symptoms in inpatients suffering from refractory obsessive-compulsive disorders (OCD)

被引：0
作者：
Mohammad Haghighi
Leila Jahangard
Hamid Mohammad-Beigi
Hafez Bajoghli
Hassan Hafezian
Alireza Rahimi
Hamid Afshar
Edith Holsboer-Trachsler
Serge Brand
机构：
[1] Hamadan University of Medical Sciences,Research Center for Behavioral Disorders and Substances Abuse
[2] Isfahan University of Medical Sciences,Isfahan Psychosomatic Research Center
[3] Tehran University of Medical Sciences,Psychiatry and Psychology Research Center (PPRC), Roozbeh Hospital
[4] Psychiatric Hospital of the University of Basel,Center for Affective, Stress and Sleep Disorders (ZASS)
来源：
Psychopharmacology | 2013年 / 228卷
关键词：
Obsessive–compulsive disorder; Memantine; SSRIs; Double-blind trial; Placebo; Y-BOCS;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：633 / 640
页数：7
相关论文
共 50 条
[21]   Adjunctive Memantine Treatment of Schizophrenia A Double-Blind, Randomized Placebo-Controlled Study [J].
Hassanpour, Fatemeh ;
Zarghami, Mehran ;
Mouodi, Sussan ;
Moosazadeh, Mahmood ;
Barzegar, Fatemeh ;
Bagheri, Maedeh ;
Hendouei, Narjes .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2019, 39 (06) :634-638
[22]   Improvement of schizophrenia negative and positive symptoms with memantine as add-on therapy to clozapine: a double-blind, randomized, placebo-controlled trial [J].
Lucena, D. ;
Fernandes, B. ;
Berk, M. ;
Dodd, S. ;
Medeiros, D. W. ;
Pedrini, M. ;
Kunz, M. ;
Gomes, F. ;
Giglio, L. ;
Lobato, M. I. ;
Belmonte-de-Abreu, P. ;
Gama, C. S. .
BIPOLAR DISORDERS, 2009, 11 :57-57
[23]   Daily Oral Memantine Attenuated the Severity of Borderline Personality Disorder Symptoms: A Double-Blind Placebo-Controlled, Randomized Clinical Trial [J].
Mohammadsadeghi, Homa ;
Soleimannejad, Maryam ;
Ramazi, Samira ;
Shalbafan, Mohammadreza ;
Ardebili, Mehrdad Eftekhar ;
Vahabzadeh, Gelareh ;
Ahmadirad, Nooshin ;
Karimzadeh, Fariba .
IRANIAN JOURNAL OF PSYCHIATRY AND BEHAVIORAL SCIENCES, 2023, 17 (02)
[24]   Memantine as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial [J].
Ghaleiha, Ali ;
Asadabadi, Mahtab ;
Mohammadi, Mohammad-Reza ;
Shahei, Maryam ;
Tabrizi, Mina ;
Hajiaghaee, Reza ;
Hassanzadeh, Elmira ;
Akhondzadeh, Shahin .
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2013, 16 (04) :783-789
[25]   A randomized, double-blind, placebo-controlled trial of pseudoephedrine in coryza [J].
Latte, J ;
Taverner, D ;
Slobodian, P ;
Shakib, S .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2004, 31 (07) :429-432
[26]   Memantine for Prophylactic Treatment of Migraine Without Aura: A Randomized Double-Blind Placebo-Controlled Study [J].
Noruzzadeh, Rezvan ;
Modabbernia, Amirhossein ;
Aghamollaii, Vajiheh ;
Ghaffarpour, Majid ;
Harirchian, Mohammad Hossein ;
Salahi, Sarvenaz ;
Nikbakht, Nikta ;
Noruzi, Nahid ;
Tafakhori, Abbas .
HEADACHE, 2016, 56 (01) :95-103
[27]   Duloxetine Augmentation in Resistant Obsessive-Compulsive Disorder A Double-Blind Controlled Clinical Trial [J].
Mowla, Arash ;
Boostani, Sanaz ;
Dastgheib, Seyed Ali .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2016, 36 (06) :720-723
[28]   A double-blind, placebo-controlled trial of memantine in age-associated memory impairment (memantine in AAMI) [J].
Ferris, Steven ;
Schneider, Lon ;
Farmer, Mildred ;
Kay, Gary ;
Crook, Thomas .
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2007, 22 (05) :448-455
[29]   Comparison of the Effects of Ketamine and Memantine on Prolactin and Cortisol Release in Men: A Randomized, Double-blind, Placebo-controlled Trial [J].
Nicole Hergovich ;
Ernst Singer ;
Ernst Agneter ;
Hans Georg Eichler ;
Ursula Graselli ;
Christian Simhandl ;
Bernd Jilma .
Neuropsychopharmacology, 2001, 24 :590-593
[30]   Comparison of the effects of ketamine and memantine on prolactin and cortisol release in men: A randomized, double-blind, placebo-controlled trial [J].
Hergovich, N ;
Singer, E ;
Agneter, E ;
Eichler, HG ;
Graselli, U ;
Simhandl, C ;
Jilma, B .
NEUROPSYCHOPHARMACOLOGY, 2001, 24 (05) :590-593
12345